Internal Medicine

A survey of pediatric subspecialists found that 9 in 10 do not follow guidelines from the American Academy of Pediatrics for treating preschoolers with ADHD.

A community pharmacist shares his insights and opinions on concerns over the risks involved with ADHD medications for children.

New research findings underscore the need for improved medical and psychiatric care coordination for HIV patients.

By providing HIV testing, counseling, screening for other STDs, transportation assistance, and other services, these programs were able to successfully identify new cases of HIV in high-risk groups and provide them with follow-up care.

The lifestyle medicine discipline offers the potential to strengthen patients' capacities to make healthier choices and foster good health.

Steven P. Levine, MD, reminds prescribers to satisfy the voices in their heads by acknowledging that any medicine may be poisonous to patients.

Mary Lynn McPherson, PharmD, BCPS, CPE, FASPE, shows healthcare professionals how to apply an equianalgesic opioid dosing chart to 12 complicated patient cases requiring an opioid switch.

Fifteen posters presented at PAINWeek 2013 demonstrate the efficacy, safety, and tolerability of a novel controlled-release combination oxycodone-acetaminophen analgesic in acute pain patients.

Post-hoc analysis of phase III clinical study results finds lubiprostone doesn't interfere with the analgesic effect of opioids in chronic non-cancer pain patients with opioid-induced constipation.

Although clinical psychiatrist Michael E. Schatman, PhD, CPE, formerly "beat the hell out of the opioid industry," he spent an hour on the PAINWeek stage supporting his new belief that "maybe it's time to stop fighting."

Two literature reviews of single-arm open-label (OL), open-label extension (OLE), and epidemiologic studies with a duration of six months or more provide evidence that long-term opioid therapy improves pain scores in chronic non-cancer pain patients.

A recent study found each missed physician visit increases an HIV patient's risk of death by 12 percent.

In a cohort of family medicine physicians, researchers found a strong inverse relationship between confidence and comfort toward opioid prescribing and concern about negative consequences.

As the doctor shopping rate for immediate-release single entity oxycodone increased by 9 percent, reformulated extended-release OxyContin's doctor shopping rate fell by 40 percent.

Lisa M. McElhaney addresses the limited education, awareness, and prevention of bullying within pain management practices.

Commander John J. Burke details how pain management practitioners can adequately protect themselves from prescription drug diverters without hurting their legitimate patients.

Jennifer E. Bolen, JD, says it's the responsibility of physicians - not labs - to ensure drug testing reports comply with federal and state guidelines in the event of an audit.

Michael R. Clark, MD, MPH, MBA, outlines the vulnerabilities that put patients with acute pain at risk of transitioning into new chronic pain.

A panel of three experts from the legal side of pain management said investigations into prescribers after patient deaths resulting from opioid overdose are rare and overblown.

When alcohol consumption is a concern, it's better to prescribe antiretroviral therapy in HIV patients than to withhold it, according to a group of researchers at University Hospital of Berne in Switzerland.

Using nutritional supplement mixtures consisting of arginine, glutamine, and beta-hydroxy-beta-methylbutyrate (HMB) may speed up wound healing in diabetic foot ulcers.

In a clinical review published in Clinical and Experimental Gastroenterology, researchers from Iwate Medical University in Japan evaluated the long-term safety and efficacy of the novel serotonin-receptor agonist ramosetron in patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D).

Even when it's administered in a low-dose form that resists gastric acid and prevents tablet dissolution in the stomach, aspirin therapy causes peptic ulcer and increases the risk of 30-day mortality resulting from gastrointestinal (GI) disorder progression.

Reviews of crofelemer showed the drug's clinical utility in diarrhea associated with HIV, but clinical trials comparing it to other antidiarrheals are still needed.

Scaling up preventative isoniazid therapy can curb tuberculosis development and related death in patients infected with HIV, according to research published online Aug. 16 in Lancet Infectious Diseases.

Fibromyalgia patients who don't respond to Lyrica (pregabalin) may see their pain scores significantly improve after adding Savella (milnacipran) to their treatment regimens.

Though many patients indicate side effects as the reason they stop taking their prescribed statins, clinical trials have not documented high discontinuation rates due to adverse drug reactions.

The US Food and Drug Administration (FDA) has approved a new tablet to treat a broad population of HIV-infected adults and children in combination with other antiretroviral (ARV) agents.

Though memory concerns voiced by older adult patients often get dismissed as normal cognitive aging, a study from two national centers devoted to Alzheimer's disease research suggests cognitive complaints from at least two sources can accurately predict a non-demented patient's risk of developing dementia.

An online commentary published in the May 22/May 29 edition of the Journal of the American Medical Association asserts that all hospitals should randomly test physicians for drug and alcohol abuse to increase patient safety.